These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A novel mutation in pmrB mediates colistin resistance during therapy of Acinetobacter baumannii. Dahdouh E; Gómez-Gil R; Sanz S; González-Zorn B; Daoud Z; Mingorance J; Suárez M Int J Antimicrob Agents; 2017 Jun; 49(6):727-733. PubMed ID: 28438568 [TBL] [Abstract][Full Text] [Related]
4. Molecular Mechanisms of Colistin Resistance Among Pandrug-Resistant Isolates of Acinetobacter baumannii with High Case-Fatality Rate in Intensive Care Unit Patients. Haeili M; Kafshdouz M; Feizabadi MM Microb Drug Resist; 2018 Nov; 24(9):1271-1276. PubMed ID: 29590004 [TBL] [Abstract][Full Text] [Related]
6. Analyzing pmrA and pmrB genes in Acinetobacter baumannii resistant to colistin in Shahid Rajai Shiraz, Iran Hospital by PCR: First report in Iran. Sepahvand S; Doudi M; Davarpanah MA; Bahador A; Ahmadi M Pak J Pharm Sci; 2016 Jul; 29(4 Suppl):1401-6. PubMed ID: 27592491 [TBL] [Abstract][Full Text] [Related]
7. In Vivo Selection of Pan-Drug Resistant Acinetobacter baumannii during Antibiotic Treatment. Kim Y; Bae IK; Jeong SH; Yong D; Lee K Yonsei Med J; 2015 Jul; 56(4):928-34. PubMed ID: 26069113 [TBL] [Abstract][Full Text] [Related]
8. Dissecting Colistin Resistance Mechanisms in Extensively Drug-Resistant Acinetobacter baumannii Clinical Isolates. Trebosc V; Gartenmann S; Tötzl M; Lucchini V; Schellhorn B; Pieren M; Lociuro S; Gitzinger M; Tigges M; Bumann D; Kemmer C mBio; 2019 Jul; 10(4):. PubMed ID: 31311879 [TBL] [Abstract][Full Text] [Related]
9. New Mutations Involved in Colistin Resistance in Acinetobacter baumannii. Sun B; Liu H; Jiang Y; Shao L; Yang S; Chen D mSphere; 2020 Apr; 5(2):. PubMed ID: 32238571 [TBL] [Abstract][Full Text] [Related]
11. Retention of virulence following adaptation to colistin in Acinetobacter baumannii reflects the mechanism of resistance. Wand ME; Bock LJ; Bonney LC; Sutton JM J Antimicrob Chemother; 2015 Aug; 70(8):2209-16. PubMed ID: 25904728 [TBL] [Abstract][Full Text] [Related]
12. Characterization of carbapenem-resistant hypervirulent Acinetobacter baumannii strains isolated from hospitalized patients in the mid-south region of China. Li J; Yu T; Luo Y; Peng JY; Li YJ; Tao XY; Hu YM; Wang HC; Zou MX BMC Microbiol; 2020 Sep; 20(1):281. PubMed ID: 32928115 [TBL] [Abstract][Full Text] [Related]
13. Diversity of amino acid substitutions in PmrCAB associated with colistin resistance in clinical isolates of Acinetobacter baumannii. Gerson S; Lucaßen K; Wille J; Nodari CS; Stefanik D; Nowak J; Wille T; Betts JW; Roca I; Vila J; Cisneros JM; Seifert H; Higgins PG Int J Antimicrob Agents; 2020 Mar; 55(3):105862. PubMed ID: 31837449 [TBL] [Abstract][Full Text] [Related]
14. Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients. Jain M; Sharma A; Sen MK; Rani V; Gaind R; Suri JC Microb Pathog; 2019 Mar; 128():75-81. PubMed ID: 30562602 [TBL] [Abstract][Full Text] [Related]
15. Promoters of Colistin Resistance in Nurtop E; Bayındır Bilman F; Menekse S; Kurt Azap O; Gönen M; Ergonul O; Can F Microb Drug Resist; 2019 Sep; 25(7):997-1002. PubMed ID: 30964377 [No Abstract] [Full Text] [Related]
16. Phenotypic changes associated with Colistin resistance due to Lipopolysaccharide loss in Acinetobacter baumannii. Carretero-Ledesma M; García-Quintanilla M; Martín-Peña R; Pulido MR; Pachón J; McConnell MJ Virulence; 2018 Dec; 9(1):930-942. PubMed ID: 29638177 [TBL] [Abstract][Full Text] [Related]
17. Emergence of Colistin- and Carbapenem-Resistant Acinetobacter baumannii ST2 Clinical Isolate in Algeria: First Case Report. Bakour S; Olaitan AO; Ammari H; Touati A; Saoudi S; Saoudi K; Rolain JM Microb Drug Resist; 2015 Jun; 21(3):279-85. PubMed ID: 25588125 [TBL] [Abstract][Full Text] [Related]
18. Emergence of colistin resistance without loss of fitness and virulence after prolonged colistin administration in a patient with extensively drug-resistant Acinetobacter baumannii. Durante-Mangoni E; Del Franco M; Andini R; Bernardo M; Giannouli M; Zarrilli R Diagn Microbiol Infect Dis; 2015 Jul; 82(3):222-6. PubMed ID: 25858028 [TBL] [Abstract][Full Text] [Related]
19. Emergence of colistin-resistance in extremely drug-resistant Acinetobacter baumannii containing a novel pmrCAB operon during colistin therapy of wound infections. Lesho E; Yoon EJ; McGann P; Snesrud E; Kwak Y; Milillo M; Onmus-Leone F; Preston L; St Clair K; Nikolich M; Viscount H; Wortmann G; Zapor M; Grillot-Courvalin C; Courvalin P; Clifford R; Waterman PE J Infect Dis; 2013 Oct; 208(7):1142-51. PubMed ID: 23812239 [TBL] [Abstract][Full Text] [Related]
20. Whole-genome shotgun sequences of seven colistin-resistant Acinetobacter baumannii isolates from bacteraemia. Vijayakumar S; S BA; Kanthan K; Veeraraghavan B J Glob Antimicrob Resist; 2018 Mar; 12():155-156. PubMed ID: 29410025 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]